Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1619-7089

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET ; volume:47 ; number:6 ; day:7 ; month:2 ; year:2020 ; pages:1486-1495 ; date:6.2020
European journal of nuclear medicine and molecular imaging ; 47, Heft 6 (7.2.2020), 1486-1495, 6.2020

Creator: Bauer, Elena K.
Stoffels, Gabriele
Blau, Tobias
Reifenberger, Guido
Felsberg, Jörg
Werner, Jan M.
Lohmann, Philipp
Rosen, Jurij
Ceccon, Garry
Tscherpel, Caroline
Rapp, Marion
Sabel, Michael
Filss, Christian P.
Shah, Nadim J.
Neumaier, Bernd
Fink, Gereon R.
Langen, Karl-Josef
Galldiks, Norbert

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00259-020-04695-0

URN: urn:nbn:de:101:1-2020070823242862415384

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:51 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bauer, Elena K.
Stoffels, Gabriele
Blau, Tobias
Reifenberger, Guido
Felsberg, Jörg
Werner, Jan M.
Lohmann, Philipp
Rosen, Jurij
Ceccon, Garry
Tscherpel, Caroline
Rapp, Marion
Sabel, Michael
Filss, Christian P.
Shah, Nadim J.
Neumaier, Bernd
Fink, Gereon R.
Langen, Karl-Josef
Galldiks, Norbert
SpringerLink (Online service)

Other Objects (12)

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET

Methylation class oligosarcoma may encompass IDH-wildtype gliomas

Therapies for IDH-Mutant Gliomas

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma

Stalled oligodendrocyte differentiation in IDH-mutant gliomas

FET-PET-based radiomics in IDH-wildtype glioblastoma

Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas

Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics

Hochschulschrift

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Hochschulschrift

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Seizures in patients with IDH-mutated lower grade gliomas

ATRX immunostaining predicts IDH and H3F3A status in gliomas

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET

Methylation class oligosarcoma may encompass IDH-wildtype gliomas

Therapies for IDH-Mutant Gliomas

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma

Stalled oligodendrocyte differentiation in IDH-mutant gliomas

FET-PET-based radiomics in IDH-wildtype glioblastoma

Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas

Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics

Hochschulschrift

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Hochschulschrift

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Seizures in patients with IDH-mutated lower grade gliomas

ATRX immunostaining predicts IDH and H3F3A status in gliomas

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET

Methylation class oligosarcoma may encompass IDH-wildtype gliomas

Therapies for IDH-Mutant Gliomas

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma

Stalled oligodendrocyte differentiation in IDH-mutant gliomas

FET-PET-based radiomics in IDH-wildtype glioblastoma

Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas

Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics

Hochschulschrift

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Hochschulschrift

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Seizures in patients with IDH-mutated lower grade gliomas

ATRX immunostaining predicts IDH and H3F3A status in gliomas

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET

Methylation class oligosarcoma may encompass IDH-wildtype gliomas

Therapies for IDH-Mutant Gliomas

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma

Stalled oligodendrocyte differentiation in IDH-mutant gliomas

FET-PET-based radiomics in IDH-wildtype glioblastoma

Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas

Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Seizures in patients with IDH-mutated lower grade gliomas

ATRX immunostaining predicts IDH and H3F3A status in gliomas

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET

Methylation class oligosarcoma may encompass IDH-wildtype gliomas

Therapies for IDH-Mutant Gliomas

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma

Stalled oligodendrocyte differentiation in IDH-mutant gliomas

FET-PET-based radiomics in IDH-wildtype glioblastoma

Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas

Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Seizures in patients with IDH-mutated lower grade gliomas

ATRX immunostaining predicts IDH and H3F3A status in gliomas

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET

Methylation class oligosarcoma may encompass IDH-wildtype gliomas

Therapies for IDH-Mutant Gliomas

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma

Stalled oligodendrocyte differentiation in IDH-mutant gliomas

FET-PET-based radiomics in IDH-wildtype glioblastoma

Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas

Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Seizures in patients with IDH-mutated lower grade gliomas

ATRX immunostaining predicts IDH and H3F3A status in gliomas

Related objects

Reset password